Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke. 2013 Aug; 8(6):479-83.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Aspirin
Blood Platelets
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Ischemic Attack, Transient
Male
Middle Aged
Platelet Aggregation Inhibitors
Research Design
Stroke
Ticlopidine
Young Adult
authors with profiles
Jordan J. Elm
Yuko Y. Palesch